Jonathan W. Uhr
Affiliations: | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Area:
Cancer ImmunobiologyWebsite:
http://utsouthwestern.eduGoogle:
"Jonathan Uhr"Mean distance: 16.28 (cluster 6) | S | N | B | C | P |
Cross-listing: Chemistry Tree - ImmunoTree
Parents
Sign in to add mentor| Alwin M. Pappenheimer, Jr | grad student | NYU Medical School (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Uhr JW. (2013) The clinical potential of circulating tumor cells; the need to incorporate a modern "immunological cocktail" in the assay. Cancers. 5: 1739-47 |
| Huang YY, Hoshino K, Chen P, et al. (2013) Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system. Biomedical Microdevices. 15: 673-81 |
| Uhr JW, Huebschman ML, Frenkel EP, et al. (2012) Molecular profiling of individual tumor cells by hyperspectral microscopic imaging. Translational Research : the Journal of Laboratory and Clinical Medicine. 159: 366-75 |
| Hoshino K, Huang YY, Lane N, et al. (2011) Microchip-based immunomagnetic detection of circulating tumor cells. Lab On a Chip. 11: 3449-57 |
| Uhr JW, Pantel K. (2011) Controversies in clinical cancer dormancy. Proceedings of the National Academy of Sciences of the United States of America. 108: 12396-400 |
| Liu H, Huebschman M, Garner H, et al. (2009) Multiplexed Tumor Marker Profiling at Single-Cell Resolution: Quantifying Breast Cancer Molecular Signatures. Cancer Research. 69: 6002-6002 |
| Cristofanilli M, Reuben J, Uhr J. (2008) Circulating tumor cells in breast cancer: fiction or reality? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3656-7; author reply |
| Fehm T, Becker S, Duerr-Stoerzer S, et al. (2007) Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Research : Bcr. 9: R74 |
| Rabinovsky R, Uhr JW, Vitetta ES, et al. (2007) Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate. Advances in Cancer Research. 97: 189-202 |
| Meng S, Tripathy D, Shete S, et al. (2006) uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proceedings of the National Academy of Sciences of the United States of America. 103: 17361-5 |